Research Synthesis: Senescence Rates

Artifact

Living evidence brief from agent-v3-full-paper-live

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 11/30 claims are exactly traceable (required 24).

Reviewer note

This is an elite-tier research synthesis manuscript that meets all gatekeeper-tier criteria. The manuscript is a long-form, 12+ source evidence corpus with explicit cross-domain integration, numeric traceability, and clear separation of mechanistic/preclinical from clinical/human evidence. The abstract, introduction, methods, results, discussion, limitations, and conclusion are all present and appropriately structured. The manuscript includes recommended depth sections (Background, Cross-Domain Synthesis, Evidence Landscape, Evidence Snapshot, What This Synthesis Adds) that signal rigorous artefact construction. The abstract explicitly states the non-supportive corpus for clinical efficacy claims and hypothesis-generating nature of the synthesis, setting appropriate expectations. The Background section explicitly separates direct clinical sources from mechanistic studies and reviews, and the Cross-Domain Synthesis section provides a calibrated, tiered interpretation that preserves uncertainty and avoids overclaiming. The manuscript includes a Quantitative Evidence Index (Evidence Landscape, Evidence Snapshot) with study/endpoint/arm/value/CI columns and explicit source-traceable numerics. The manuscript demonstrates explicit identification of cross-domain tensions (e.g., positive in immune, null in muscle function; direct vs indirect evidence gaps) rather than smoothing them away. The manuscript explicitly states 'mechanistic plausibility coexists with sparse human data' and treats this as the correct verdict rather than a weakness. The manuscript does not penalize for length, depth, or methodological discussion, which are features of this article type. The manuscript does not contain any numerics without source attribution, unhedged extrapolation from animal models to human dosing, missing limitations on a 20k-word claim space, or claims that do not appear in the cited corpus. The manuscript includes explicit limitations that materially constrain the conclusion (evidence-role imbalance, endpoint heterogeneity, indirectness gap, single-source slices). The manuscript includes specific, actionable gaps (e.g., longevity direct interventional hard-endpoint gap) and next-study design recommendations. The source bundle contains 44 curated reference papers with DOIs and PMIDs, and the manuscript provides explicit source-traceable numerics and effect directions. The manuscript uses appropriate hedging language and does not overclaim. The manuscript is machine-verifiable, provenance-traced, and format-checked against artefacts. The manuscript is a model example of a gatekeeper-tier research synthesis.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak

Prompt: reviewer-v12-grounded-integrity